Kidney cancer: Clinical practice guidelines

Robert J. Motzer*, Michael A. Carducci, Mayer Fishman, Steven L. Hancock, Ralph J. Hauke, Gary R. Hudes, Philip Kantoff, Timothy M. Kuzel, Paul H. Lange, Ellis G. Levine, Chris Logothetis, Kim A. Margolin, Roberto Pili, Kamal S. Pohar, Bruce G. Redman, Sylvia Richey, Cary N. Robertson, Wolfram E. Samlowski, Joel Sheinfeld, Donald A. Urban

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

An estimated 35,710 new cases of kidney cancer will have been diagnosed in 2004, and more than 12,000 patients will have died of the disease in the United States. Renal cell carcinoma comprises 2% to 3% of all malignancies, with the highest incidence in the sixth decade of life. Smoking and obesity are among the risk factors for developing this disease, and tumor grade and stage are important for predicting patient outcomes after nephrectomy. These guidelines discuss evaluation, staging, treatment, and management after treatment.

Original languageEnglish (US)
Pages (from-to)84-93
Number of pages10
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume3
Issue number1
StatePublished - Jan 1 2005

Keywords

  • Clear cell tumors
  • Kidney disease
  • NCCN Clinical Practice Guidelines
  • Nephrectomy
  • Renal cell carcinoma
  • Von Hippel-Lindau syndrome

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Kidney cancer: Clinical practice guidelines'. Together they form a unique fingerprint.

Cite this